OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2.60 Cr | ₹-13 Cr | ₹-1.63 Cr | ₹-1.68 Cr | ₹-1.62 Cr |
What is the latest Cash Flow from Operating Activities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹2.60 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹-1.63 Cr |
| Mar2022 | ₹-1.68 Cr |
| Mar2021 | ₹-1.62 Cr |
How is Cash Flow from Operating Activities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.60 Cr | Positive | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹-1.63 Cr | Negative | |
| Mar2022 | ₹-1.68 Cr | Negative | |
| Mar2021 | ₹-1.62 Cr | - | |
Compare Cash Flow from Operating Activities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹184.1 Cr | 3% | -6.8% | -37.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 3% |
-6.8% |
-37.5% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses